Skip to content
Open access

Pulmonary Function Test in Chronic Obstructive Pulmonary Disease Related to Diffusion Lung Capacity for Carbon Monoxide and Six-minute Walk Test at Tertiary Care Center

Sep 2026 · Journal of Advanced Lung Health · 0 citations · 20 references

TL;DR

DLCO’s significant association with GOLD stage and 6MWT highlights its potential in routine COPD evaluation, and incorporating DLCO into clinical practice may enhance patient stratification, guide therapy, and improve prognostication.

Abstract

A BSTRACT Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterized by airflow limitation. Spirometry forms the cornerstone of diagnosis. Additional parameters, such as diffusing capacity for carbon monoxide (DLCO) and 6-min walk test (6MWT), can offer deeper insights into disease severity and prognosis. This study aimed to evaluate the clinical, radiological, and functional profiles of COPD patients and explore correlations. This prospective observational study included 201 patients diagnosed with COPD at a tertiary care center. Detailed clinical, spirometry, DLCO, 6MWT, arterial blood gas (ABG), chest X-ray, and computed tomography of the thorax were performed. Statistical analysis was conducted using Spearman’s correlation between DLCO, Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage, and 6MWT. The mean age was 56.73 ± 12.93 years, with a male predominance (65%). Past tuberculosis (53.73%) and smoking (39.8%) were the leading etiologies. Most patients were in GOLD stage 3 (44%) and CAG Class E (54%). ABG analysis was normal in 78.11% of cases, while 47% of cases had pulmonary hypertension. DLCO was severely reduced (<40%) in 97.39% of tested patients, and 62.69% of cases showed significant desaturation (≥4%) on 6MWT, with 72.14% covering 150–249 m. Chest imaging showed hyperinflation, fibrosis, and bronchiectasis. A significant negative correlation was found between DLCO and GOLD stage (ρ = −0.3169, P < 0.001) and a positive correlation between DLCO and 6MWT distance (ρ = 0.4153, P < 0.001). DLCO’s significant association with GOLD stage and 6MWT highlights its potential in routine COPD evaluation. Incorporating DLCO into clinical practice may enhance patient stratification, guide therapy, and improve prognostication.

Read PDF

Similar papers

Open access Sep 2026

Forced Vital Capacity and Six-Minute Walk Test as Indicators of Interstitial Lung Disease Extent on High-Resolution Computed Tomography in Systemic Sclerosis

Abstract Introduction Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in systemic sclerosis (SSc). High-resolution computed tomography (HRCT) is the gold standard for assessing ILD extent but is limited by cost, availability, and radiation exposure. Practical functional tools are thus need...

S. Halim, C. M. Rumende, R. S. A. K. Wibowo et al. · 0 citations
Open access Oct 2026

Role Of Spirometry in Discriminating Pre-Chronic Obstructive Pulmonary Disease Preserved Ratio Impaired Spirometry and Chronic Obstructive Pulmonary Disease in Smokers: A Cross-Sectional Study

COPD was the most frequent diagnosis but a considerable proportion of smokers had Pre-COPD and PRISm before developing COPD which emphasizes the need for early screening with spirometry in high risk individuals.

Umer Rasul Awan, Z. Akhtar, M. Musharaf et al. · 0 citations
Review Open access Sep 2026

Quantitative Computed Tomography assessment of pulmonary emphysema: Current applications, clinical correlations, and environmental influences with insights from Northeastern China

The clinical-radiographic correlation and environmental factors associated with emphysema are emphasized, current research gaps in quantitative emphysema assessment among dyspneic patients in northeastern China are highlighted, and the need for additional radiographic and epidemiologic data from the region is emphasize...

Madan Ratna Neupane, Jeetendra Bhandari, Kamal Dhungana et al. · 0 citations
Open access Oct 2026

The diagnostic blind spot of spirometric staging in biomass-related non-smoking chronic obstructive pulmonary disease: a cross-sectional study of spirometry-diffusion discordance in a rural South Indian population.

Chronic obstructive pulmonary disease (COPD) is heterogeneous, yet severity is conventionally graded by spirometry [forced expiratory volume in 1 second (FEV1)] on the assumption that airflow limitation reflects parenchymal damage. Biomass-related non-smoking COPD (NS-COPD) is common in low- and middle-income countries...

Chittin N. Swamy, Sandeepa H. S., Deepu C. C. et al. · 0 citations
Open access Oct 2026

Pulmonary diffusion capacity to select patients for echocardiographic evaluation of pulmonary hypertension in interstitial lung disease: Impact of interstitial lung disease phenotype.

BACKGROUND Treprostinil inhalation for pulmonary hypertension (PH) with interstitial lung disease (ILD) has increased the importance of PH screening. We aimed to determine whether pulmonary function tests performed for ILD management could identify patients with possible PH on echocardiography, according to ILD subtype...

Noriaki Ito, T. Masuda, K. Shimoji et al. · 0 citations
Open access Oct 2026

Quantitative CT features for COPD classification and GOLD spirometric severity assessment: a single-center model-development study

Background Chronic obstructive pulmonary disease (COPD) is diagnosed primarily by post-bronchodilator spirometry, but quantitative CT can characterize emphysema and visible-airway structural abnormalities that are not fully captured by airflow measurements alone. Because CT-derived emphysema and airway features have be...

Kai-Feng Du, Jia-Meng Gao, Ji Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.